Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients

被引:0
|
作者
Silva-Cardenas, D. C. [1 ]
Pikabea-Diaz, F. [1 ]
Zumarraga-Cuesta, A. [1 ]
Lopez-Santillan, M. [1 ]
Figaredo-Berjano, C. [1 ]
Loaiza-Jaramillo, P. L. [1 ]
Casado-Cuesta, P. [1 ]
Temino-Frances, M. [1 ]
Lopez-de-San-Vicente-Hernandez, B. [1 ]
Novo-Sukia, E. [1 ]
Legaspi-Folgueira, J. [1 ]
Barcelo-Galindez, J. R. [1 ]
Sande-Sardina, L. [1 ]
Nuno-Escolastico, M. [1 ]
Abad-Villar, M. T. [1 ]
Sala-Gonzalez, M. A. [1 ]
Galve-Calvo, E. [1 ]
Martinez-del-Prado, M. P. [1 ]
机构
[1] Basurto Univ Hosp, Med Oncol Serv, OSI Bilbao Basurto, Bilbao, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PO-14
引用
收藏
页码:S17 / S17
页数:1
相关论文
共 50 条
  • [1] Real-World Anticoagulant Use and Incidence of Venous Thromboembolism and Major Bleeding in Children
    Hardin, Jill
    Michelson, Alan D.
    McCrindle, Brian W.
    Pina, L. Miriam
    Peluso, Colleen
    Simpkins, Pamela
    Truong, Huy
    Knoll, Christopher
    Yuan, Zhong
    CLINICAL THERAPEUTICS, 2021, 43 (12) : 2074 - 2087
  • [2] Predicting recurrence of venous thromboembolism in anticoagulated cancer patients using real-world data and machine learning.
    Martin, Andres J. Munoz
    Dominguez, Sofia Huerga
    Souto, Juan Carlos
    Revuelta, Jacobo Rogado
    Sanchez, Antonio
    Garcia-Palomo, Andres
    Aparicio, Jorge
    Aguayo, Cristina
    Abad, David Gutierrez
    Ortega, Laura
    Vinuela-Beneitez, Maria Carmen
    Fanjul, Victor
    Casadevall, David
    Arumi, Daniel
    Hernandez-Presa, Miguel Angel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18742 - E18742
  • [3] Risk of recurrence and bleeding with Rivaroxaban among patients with venous thromboembolism and active cancer
    Sogaard, M.
    Nielsen, P. B.
    Skjoth, F.
    Kjaeldgaard, J. N.
    Larsen, T. B.
    THROMBOSIS RESEARCH, 2018, 164 : S240 - S240
  • [4] Venous Thromboembolism in Patients With Myeloma: Incidence and Risk Factors in a "Real-World" Population
    Crowley, Maeve P.
    Eustace, Joseph A.
    O'Shea, Susan I.
    Gilligan, Oonagh M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (06) : 600 - 606
  • [5] Predicting major bleeding events in anticoagulated cancer patients with venous thromboembolism using real-world data and machine learning.
    Martin, Andres J. Munoz
    Palacios, Maria Luisa
    Souto, Juan Carlos
    Obispo, Berta
    Aparicio, Jorge
    Garcia-Palomo, Andres
    Sanchez, Antonio
    Aguayo, Cristina
    Abad, David Gutierrez
    Vinuela-Beneitez, Maria Carmen
    Benavent, Diego
    Taberna, Miren
    Arumi, Daniel
    Hernandez-Presa, Miguel Angel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18744 - E18744
  • [6] Generic Dabigatran for Cancer-Associated Venous Thromboembolism: Real-World Data
    Saj, Fen
    Kayal, Smita
    Dubashi, Biswajit
    Ganesan, Prasanth
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (04) : 721 - 722
  • [7] Generic dabigatran for cancer-associated venous thromboembolism: Real-world data
    Saj, F.
    Dubashi, B.
    Kayal, S.
    Ganesan, P.
    ANNALS OF ONCOLOGY, 2022, 33 : 1545 - 1546
  • [8] Risk of recurrent venous thromboembolism and bleeding with apixaban versus rivaroxaban: an analysis of real-world data
    Villoing, B.
    ANNALES FRANCAISES DE MEDECINE D URGENCE, 2022, 12 (02): : 131 - 131
  • [9] Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data
    Dawwas, Ghadeer K.
    Leonard, Charles E.
    Lewis, James D.
    Cuker, Adam
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (01) : 20 - +
  • [10] Utility of Rivaroxaban for Real-World Patients With Venous Thromboembolism
    Yamashita, Yugo
    CIRCULATION JOURNAL, 2023, 87 (09) : 1185 - 1186